Home NDC 43353-015 Azilect
Product NDC 43353-015
11-digit product format 433530015
Labeler code 43353
Product ID 43353-015_7a05b579-97d9-4b52-8998-b95a634e674e
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Rasagiline Mesylate
Dosage form TABLET
Route ORAL
Labeler Aphena Pharma Solutions - Tennessee, LLC
Application NDA021641
Marketing category NDA
Marketing start 2006-07-10
Marketing end 0000-00-00
Substance RASAGILINE MESYLATE
Active strength 1 mg/1
Pharmacologic classes Monoamine Oxidase Inhibitor [EPC],Monoamine Oxidase Inhibitors [MoA]
NDC exclude flag No
Listing certified through 2019-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 42 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 43353-015-18 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 43353-015-18 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 43353-015-18 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 43353-015-18 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 43353-015-18 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 43353-015-18 cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 43353-015-18 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 43353-015-18 ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 43353-015-18 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 excluded product product ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 43353-015-18 ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 excluded product product 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 43353-015-18 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 excluded product product 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 43353-015-18 557ba5c1ecfa…9c80585c8c6e…2024-05-28 21:12 UTC · source 2024-05-28 excluded product product 8af77b9d5b6f…d9bbb34c5368…2024-05-28 21:12 UTC · source 2024-05-28 excluded package package 43353-015-18 8af77b9d5b6f…d9bbb34c5368…2024-05-15 03:39 UTC · source 2024-05-14 excluded product product 834df4deac94…adcc014656a3…2024-05-15 03:39 UTC · source 2024-05-14 excluded package package 43353-015-18 834df4deac94…adcc014656a3…2024-03-11 06:39 UTC · source 2024-03-08 excluded product product 1332a3947898…d4bfe170f9cd…2024-03-11 06:39 UTC · source 2024-03-08 excluded package package 43353-015-18 1332a3947898…d4bfe170f9cd…2022-08-30 03:57 UTC · source 2022-08-29 excluded product product fb8cb913e6d1…eb8c232b6be0…2022-08-30 03:57 UTC · source 2022-08-29 excluded package package 43353-015-18 fb8cb913e6d1…eb8c232b6be0…2022-04-09 23:13 UTC · source 2022-04-08 excluded product product 86f5da6cb304…a595104c45d7…2022-04-09 23:13 UTC · source 2022-04-08 excluded package package 43353-015-18 86f5da6cb304…a595104c45d7…2022-04-04 05:40 UTC · source 2022-04-01 excluded product product bd6a592717d7…303034d00443…2022-04-04 05:40 UTC · source 2022-04-01 excluded package package 43353-015-18 bd6a592717d7…303034d00443…2021-12-27 23:28 UTC · source 2021-12-27 excluded product product 8dfbde2a14a4…c9ff85d89658…2021-12-27 23:28 UTC · source 2021-12-27 excluded package package 43353-015-18 8dfbde2a14a4…c9ff85d89658…2020-12-18 03:04 UTC · source 2020-12-17 excluded product product e2bbac7714bc…27bdfed8d636…2020-12-18 03:04 UTC · source 2020-12-17 excluded package package 43353-015-18 e2bbac7714bc…27bdfed8d636…2020-06-10 20:45 UTC · source 2020-06-10 excluded product product 9bebd1f3094a…5416666fcb17…2020-06-10 20:45 UTC · source 2020-06-10 excluded package package 43353-015-18 9bebd1f3094a…5416666fcb17…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N021641-001 AZILECT RASAGILINE MESYLATE EQ 0.5MG BASE TABLET / ORAL AB RLD 2006-05-16 N021641-002 AZILECT RASAGILINE MESYLATE EQ 1MG BASE TABLET / ORAL AB RLD, RS 2006-05-16
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 2 matching rows.
Orange Book patents# Current patent rows page 1 of 1 · 4 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N021641-001 7572834 2026-12-05 Drug product N021641-001 7815942 2027-08-27 U-219 Drug substance, Drug product 2010-11-08 N021641-002 7572834 2026-12-05 Drug product N021641-002 7815942 2027-08-27 U-219 Drug substance, Drug product
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 3 · 82 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N021641-001 AZILECT EQ 0.5MG BASE TABLET / ORAL AB RLD 2006-05-16 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021641-002 AZILECT EQ 1MG BASE TABLET / ORAL AB RLD, RS 2006-05-16 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021641-001 AZILECT EQ 0.5MG BASE TABLET / ORAL AB RLD 2006-05-16 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021641-002 AZILECT EQ 1MG BASE TABLET / ORAL AB RLD, RS 2006-05-16 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N021641-001 AZILECT EQ 0.5MG BASE TABLET / ORAL AB RLD 2006-05-16 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N021641-002 AZILECT EQ 1MG BASE TABLET / ORAL AB RLD, RS 2006-05-16 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021641-001 AZILECT EQ 0.5MG BASE TABLET / ORAL AB RLD 2006-05-16 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021641-002 AZILECT EQ 1MG BASE TABLET / ORAL AB RLD, RS 2006-05-16 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021641-001 AZILECT EQ 0.5MG BASE TABLET / ORAL AB RLD 2006-05-16 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021641-002 AZILECT EQ 1MG BASE TABLET / ORAL AB RLD, RS 2006-05-16 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021641-001 AZILECT EQ 0.5MG BASE TABLET / ORAL AB RLD 2006-05-16 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021641-002 AZILECT EQ 1MG BASE TABLET / ORAL AB RLD, RS 2006-05-16 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021641-001 AZILECT EQ 0.5MG BASE TABLET / ORAL AB RLD 2006-05-16 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021641-002 AZILECT EQ 1MG BASE TABLET / ORAL AB RLD, RS 2006-05-16 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N021641-001 AZILECT EQ 0.5MG BASE TABLET / ORAL AB RLD 2006-05-16 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N021641-002 AZILECT EQ 1MG BASE TABLET / ORAL AB RLD, RS 2006-05-16 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N021641-001 AZILECT EQ 0.5MG BASE TABLET / ORAL AB RLD 2006-05-16 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N021641-002 AZILECT EQ 1MG BASE TABLET / ORAL AB RLD, RS 2006-05-16 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N021641-001 AZILECT EQ 0.5MG BASE TABLET / ORAL AB RLD 2006-05-16 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N021641-002 AZILECT EQ 1MG BASE TABLET / ORAL AB RLD, RS 2006-05-16 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N021641-001 AZILECT EQ 0.5MG BASE TABLET / ORAL AB RLD 2006-05-16 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N021641-002 AZILECT EQ 1MG BASE TABLET / ORAL AB RLD, RS 2006-05-16 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N021641-001 AZILECT EQ 0.5MG BASE TABLET / ORAL AB RLD 2006-05-16 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N021641-002 AZILECT EQ 1MG BASE TABLET / ORAL AB RLD, RS 2006-05-16 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N021641-001 AZILECT EQ 0.5MG BASE TABLET / ORAL AB RLD 2006-05-16 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N021641-002 AZILECT EQ 1MG BASE TABLET / ORAL AB RLD, RS 2006-05-16 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N021641-001 AZILECT EQ 0.5MG BASE TABLET / ORAL AB RLD 2006-05-16 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 N021641-002 AZILECT EQ 1MG BASE TABLET / ORAL AB RLD, RS 2006-05-16 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N021641-001 AZILECT EQ 0.5MG BASE TABLET / ORAL AB RLD 2006-05-16 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N021641-002 AZILECT EQ 1MG BASE TABLET / ORAL AB RLD, RS 2006-05-16 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N021641-001 AZILECT EQ 0.5MG BASE TABLET / ORAL AB RLD 2006-05-16 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 N021641-002 AZILECT EQ 1MG BASE TABLET / ORAL AB RLD, RS 2006-05-16 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N021641-001 AZILECT EQ 0.5MG BASE TABLET / ORAL AB RLD 2006-05-16 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 N021641-002 AZILECT EQ 1MG BASE TABLET / ORAL AB RLD, RS 2006-05-16 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N021641-001 AZILECT EQ 0.5MG BASE TABLET / ORAL AB RLD 2006-05-16 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021641-002 AZILECT EQ 1MG BASE TABLET / ORAL AB RLD, RS 2006-05-16 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 N021641-001 AZILECT EQ 0.5MG BASE TABLET / ORAL AB RLD 2006-05-16 bb7c543d1eb4…2022-03-09 01:35 UTC 2022-03 N021641-002 AZILECT EQ 1MG BASE TABLET / ORAL AB RLD, RS 2006-05-16 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N021641-001 AZILECT EQ 0.5MG BASE TABLET / ORAL AB RLD 2006-05-16 782e0a99824c…2021-12-28 21:50 UTC 2021-12 N021641-002 AZILECT EQ 1MG BASE TABLET / ORAL AB RLD, RS 2006-05-16 782e0a99824c…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 3 · 82 observed states.
Observed Orange Book patent history# Patent history page 1 of 5 · 164 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N021641-001 7572834 2026-12-05 Drug product 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021641-001 7815942 2027-08-27 U-219 Drug substance, Drug product 2010-11-08 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021641-002 7572834 2026-12-05 Drug product 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021641-002 7815942 2027-08-27 U-219 Drug substance, Drug product 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021641-001 7572834 2026-12-05 Drug product 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021641-001 7815942 2027-08-27 U-219 Drug substance, Drug product 2010-11-08 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021641-002 7572834 2026-12-05 Drug product 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021641-002 7815942 2027-08-27 U-219 Drug substance, Drug product 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N021641-001 7572834 2026-12-05 Drug product 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N021641-001 7815942 2027-08-27 U-219 Drug substance, Drug product 2010-11-08 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N021641-002 7572834 2026-12-05 Drug product 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N021641-002 7815942 2027-08-27 U-219 Drug substance, Drug product 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021641-001 7572834 2026-12-05 Drug product fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021641-001 7815942 2027-08-27 U-219 Drug substance, Drug product 2010-11-08 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021641-002 7572834 2026-12-05 Drug product fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021641-002 7815942 2027-08-27 U-219 Drug substance, Drug product fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021641-001 7572834 2026-12-05 Drug product b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021641-001 7815942 2027-08-27 U-219 Drug substance, Drug product 2010-11-08 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021641-002 7572834 2026-12-05 Drug product b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021641-002 7815942 2027-08-27 U-219 Drug substance, Drug product b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021641-001 7572834 2026-12-05 Drug product 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021641-001 7815942 2027-08-27 U-219 Drug substance, Drug product 2010-11-08 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021641-002 7572834 2026-12-05 Drug product 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021641-002 7815942 2027-08-27 U-219 Drug substance, Drug product 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021641-001 7572834 2026-12-05 Drug product 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021641-001 7815942 2027-08-27 U-219 Drug substance, Drug product 2010-11-08 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021641-002 7572834 2026-12-05 Drug product 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021641-002 7815942 2027-08-27 U-219 Drug substance, Drug product 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N021641-001 7572834 2026-12-05 Drug product 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N021641-001 7815942 2027-08-27 U-219 Drug substance, Drug product 2010-11-08 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N021641-002 7572834 2026-12-05 Drug product 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N021641-002 7815942 2027-08-27 U-219 Drug substance, Drug product 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N021641-001 7572834 2026-12-05 Drug product d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N021641-001 7815942 2027-08-27 U-219 Drug substance, Drug product 2010-11-08 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N021641-002 7572834 2026-12-05 Drug product d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N021641-002 7815942 2027-08-27 U-219 Drug substance, Drug product d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N021641-001 7572834 2026-12-05 Drug product d06236e962d9…2024-10-29 15:01 UTC 2024-10 N021641-001 7815942 2027-08-27 U-219 Drug substance, Drug product 2010-11-08 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N021641-002 7572834 2026-12-05 Drug product d06236e962d9…2024-10-29 15:01 UTC 2024-10 N021641-002 7815942 2027-08-27 U-219 Drug substance, Drug product d06236e962d9…
DailyMed Product Concepts# FDA-Initiated Inactive NDC Indexing# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 43353-015-18 Azilect 3000 in 1 BOTTLE TABLET 3000 2
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 43353-015 AZILECT (RASAGILINE MESYLATE) TABLET [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] 2 Legacy NDC, 1 package rows 20170629_73efe275-acea-49c0-aa76-fdc4249c424e.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 2 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Status 43353-015-18 43353001518 3000 in 1 BOTTLE Historical